Live tape
Top 8, mentions 7d14,333GOOGL2,869 mentions▲ +0.04NVDA2,215 mentions▲ +0.05AMD1,940 mentions▲ +0.08QQQ1,751 mentions▲ +0.05AAPL1,729 mentions▲ +0.05SPY1,560 mentions▲ +0.06TSLA1,164 mentions▲ +0.06SPCX1,105 mentions▲ +0.05

Equity · Healthcare

EVH

NYSE

Evolent Health (EVH)

3 USD −5.36% vs prior close
Evolent Health, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for EVH to draw a line in its place.

Track this symbol on TradingView
Market cap
339.3M USD
Revenue, year to Dec 2025
1.9B USD
EPS, diluted, year to Dec 2025
−5.07 USD
52-week range
2.16 USD – 10.06 USD
Avg volume
628.2K

as of Jul 31, 2026

Have Evolent Health (EVH) insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Evolent Health insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 18 Nov 2025.

Form 4, 90 days to 9 Nov 2026, newest reported trade 26 Aug 2026

Buys 0Sells 1Net sold $329KOther filings 0

Have Evolent Health (EVH) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
26 Aug 2026McCarthy Daniel JosephPRESIDENTSell65,892329K USD

Which funds hold Evolent Health (EVH)?

10 of the 45 institutional funds we track reported a Evolent Health position for the quarter ended 30 Jun 2026 — a combined 69.6M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Evolent Health (EVH)?
FundPositionSharesValueShares q/q
D. E. Shaw & Co.Held (±25%)5,107,56127.7M USD−6.0%
Marshall WaceAdded3,413,24518.5M USD+334.8%
Two Sigma InvestmentsAdded1,263,6536.8M USD+45.0%
AQR Capital ManagementAdded792,7684.3M USD+355.6%
Tudor Investment CorpAdded699,2673.8M USD+579.8%
Man GroupAdded498,2722.7M USD+414.3%
Citadel AdvisorsTrimmed488,8142.6M USD−30.7%
Millennium ManagementHeld (±25%)303,3431.6M USD−19.3%
GAMCO InvestorsHeld (±25%)247,5001.3M USD−14.5%
Balyasny Asset ManagementTrimmed30,523165K USD−92.0%

What has been filed or recorded for Evolent Health (EVH)?

The filings we hold for Evolent Health, newest first: 3 fails-to-deliver days, 4 quarterly earnings reports, 3 annual reports and 5 reported financial figures, the latest dated 02 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Evolent Health (EVH)?
And
02 Oct 2026Fails to deliverShares failed to deliver114,237 shares387K USD notional · 0.101% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.21 USD
30 Sep 2026FinancialsTotal assets2.0B USDat period end
30 Sep 2026FinancialsTotal equity372.9M USDat period end
29 Sep 2026Fails to deliverShares failed to deliver99,962 shares365K USD notional · 0.088% of shares out
28 Sep 2026Fails to deliverShares failed to deliver100,000 shares361K USD notional · 0.088% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.25 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.24 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −3.84 USD
31 Dec 2025FinancialsRevenue1.9B USDfiscal year
31 Dec 2025FinancialsNet income−534.5M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−5.07 USDfiscal year
30 Sep 2025Annual reportFY 2025 reportedEPS −0.24 USD
30 Jun 2025Annual reportFY 2025 reportedEPS −0.44 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.63 USD

Evolent Health (EVH): frequently asked questions

From live data
339.3M

What is Evolent Health’s market cap?

Evolent Health is worth 339.3M USD by market value as of 31 Jul 2026, which is the share price times the shares on issue from its SEC filings.

1.9B

What is Evolent Health’s revenue?

Evolent Health reported revenue of 1.9B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

1 sale

Have Evolent Health insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Evolent Health insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 18 Nov 2025. See Insiders

10 of 45

Which funds own Evolent Health?

10 of the 45 funds we track reported a Evolent Health position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Marshall Wace and Two Sigma Investments. See Funds

−0.21

When did Evolent Health last report earnings?

Evolent Health last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.21 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings